Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody that targets cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and antagonizes CTLA-4-mediated inhibitory immune checkpoints, thereby enhancing immune cell activation, Zalifrelimab is widely used in immuno-oncology research to study immune checkpoint blockade and antitumor immune responses.
Purity:
95.00%
CAS Number:
[2148321-69-9]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted